VIKING THERAPEUTICS INC's ticker is VKTX and the CUSIP is 92686J106. A total of 196 filers reported holding VIKING THERAPEUTICS INC in Q2 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $993 | +1.4% | 89,741 | +48.5% | 0.08% | -13.3% |
Q2 2023 | $979 | -49.3% | 60,422 | -47.9% | 0.10% | -48.7% |
Q1 2023 | $1,932 | -4.7% | 116,040 | -46.2% | 0.19% | -24.2% |
Q4 2022 | $2,027 | -99.7% | 215,651 | -2.6% | 0.25% | +215.0% |
Q3 2022 | $602,000 | +24.4% | 221,483 | +32.3% | 0.08% | +9.6% |
Q2 2022 | $484,000 | +15.5% | 167,356 | +19.8% | 0.07% | +30.4% |
Q1 2022 | $419,000 | +18.7% | 139,664 | +82.1% | 0.06% | +27.3% |
Q4 2021 | $353,000 | +5.1% | 76,700 | +43.2% | 0.04% | +29.4% |
Q3 2021 | $336,000 | +65.5% | 53,578 | +57.8% | 0.03% | +47.8% |
Q2 2021 | $203,000 | -46.2% | 33,960 | -43.1% | 0.02% | -63.5% |
Q1 2021 | $377,000 | -8.5% | 59,641 | -18.4% | 0.06% | -6.0% |
Q4 2020 | $412,000 | +554.0% | 73,099 | +570.6% | 0.07% | +509.1% |
Q3 2020 | $63,000 | -38.8% | 10,901 | -19.3% | 0.01% | -8.3% |
Q4 2018 | $103,000 | -72.0% | 13,507 | -36.0% | 0.01% | -40.0% |
Q3 2018 | $368,000 | -31.1% | 21,100 | -62.5% | 0.02% | -23.1% |
Q2 2018 | $534,000 | – | 56,300 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Affinity Asset Advisors, LLC | 622,249 | $10,360,446 | 3.42% |
GREAT POINT PARTNERS LLC | 1,000,000 | $16,650,000 | 3.27% |
Ghost Tree Capital, LLC | 600,000 | $9,990,000 | 2.95% |
SILVERARC CAPITAL MANAGEMENT, LLC | 380,000 | $6,327,000 | 2.61% |
Integral Health Asset Management, LLC | 727,100 | $12,106,215 | 2.44% |
Sio Capital Management, LLC | 250,000 | $4,162,500 | 2.06% |
Boxer Capital, LLC | 2,000,000 | $33,300 | 1.64% |
DAFNA Capital Management LLC | 319,155 | $5,313,931 | 1.59% |
5AM Venture Management, LLC | 350,000 | $5,827,500 | 1.49% |
Monashee Investment Management LLC | 300,000 | $4,995,000 | 1.38% |